Description
EMBO Installation Grants support early-career scientists establishing independent laboratories in one of eight participating EMBC Member States (Croatia, Czech Republic, Estonia, Lithuania, Montenegro, Poland, Portugal and Turkey) that fund their respective grantees. At present call in 2021, Installation Grant applications are accepted by the Czech Republic, Estonia, Poland, Portugal, Montenegro, Lithuania and Turkey with the aim of strengthening the life sciences in these countries. EMBO subject areas: Cell Cycle, Cell & Tissue Architecture, Cellular Metabolism, Chromatin & Transcription, Development, Differentiation & Death, Evolution & Ecology, Genome Stability & Dynamics, Genomic & Computational Biology, Immunology, Membranes & Transport, Microbiology, Virology & Pathogens, Molecular Medicine, Neuroscience, Plant Biology, Proteins & Biochemistry, RNA, Signal Transduction, Structural Biology & Biophysics, Systems Biology. Eligibility Candidates must: Be negotiating a full-time group leader position at an institute/university in the Czech Republic, Estonia, Poland, Portugal, Lithuania, Montenegro or Turkey by the date of application or have established a laboratory in one of these countries in the last two years. Have spent at least two consecutive years outside the country in which they are planning to establish their laboratory in the four years prior to application. Have received their PhD less than nine years prior to application. For female candidates with children, 9-years since PhD is automatically extended by one year per child. For male applicants with children, these limits can be extended by the actual time taken off as paternity leave or - if their partner is working at least 80 percent FTE (full-time equivalent) - three months per child, whichever is longer. illness and extended military service are considered as exceptional circumstances on a case-by-case basis. Special provision may also be made for clinical scientists. Be able to attend an interview in Heidelberg, Germany, on 8 November 2021.